Literature DB >> 29477072

Family-wide analysis of aminoacyl-sulfamoyl-3-deazaadenosine analogues as inhibitors of aminoacyl-tRNA synthetases.

Baole Zhang1, Steff De Graef2, Manesh Nautiyal1, Luping Pang3, Bharat Gadakh1, Matheus Froeyen1, Lieve Van Mellaert4, Sergei V Strelkov2, Stephen D Weeks2, Arthur Van Aerschot5.   

Abstract

Aminoacyl-tRNA synthetases (aaRSs) are enzymes that precisely attach an amino acid to its cognate tRNA. This process, which is essential for protein translation, is considered a viable target for the development of novel antimicrobial agents, provided species selective inhibitors can be identified. Aminoacyl-sulfamoyl adenosines (aaSAs) are potent orthologue specific aaRS inhibitors that demonstrate nanomolar affinities in vitro but have limited uptake. Following up on our previous work on substitution of the base moiety, we evaluated the effect of the N3-position of the adenine by synthesizing the corresponding 3-deazaadenosine analogues (aaS3DAs). A typical organism has 20 different aaRS, which can be split into two distinct structural classes. We therefore coupled six different amino acids, equally targeting the two enzyme classes, via the sulfamate bridge to 3-deazaadenosine. Upon evaluation of the inhibitory potency of the obtained analogues, a clear class bias was noticed, with loss of activity for the aaS3DA analogues targeting class II enzymes when compared to the equivalent aaSA. Evaluation of the available crystallographic structures point to the presence of a conserved water molecule which could have importance for base recognition within class II enzymes, a property that can be explored in future drug design efforts.
Copyright © 2018 Elsevier Masson SAS. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 29477072     DOI: 10.1016/j.ejmech.2018.02.013

Source DB:  PubMed          Journal:  Eur J Med Chem        ISSN: 0223-5234            Impact factor:   6.514


  5 in total

Review 1.  Progress and challenges in aminoacyl-tRNA synthetase-based therapeutics.

Authors:  Christopher S Francklyn; Patrick Mullen
Journal:  J Biol Chem       Date:  2019-01-22       Impact factor: 5.157

2.  Synthesis and Biological Evaluation of Lipophilic Nucleoside Analogues as Inhibitors of Aminoacyl-tRNA Synthetases.

Authors:  Manesh Nautiyal; Bharat Gadakh; Steff De Graef; Luping Pang; Masroor Khan; Yi Xun; Jef Rozenski; Arthur Van Aerschot
Journal:  Antibiotics (Basel)       Date:  2019-10-09

Review 3.  Aminoacyl-tRNA Synthetases as Valuable Targets for Antimicrobial Drug Discovery.

Authors:  Luping Pang; Stephen D Weeks; Arthur Van Aerschot
Journal:  Int J Mol Sci       Date:  2021-02-10       Impact factor: 5.923

4.  Partitioning of the initial catalytic steps of leucyl-tRNA synthetase is driven by an active site peptide-plane flip.

Authors:  Luping Pang; Vladimir Zanki; Sergei V Strelkov; Arthur Van Aerschot; Ita Gruic-Sovulj; Stephen D Weeks
Journal:  Commun Biol       Date:  2022-08-29

5.  Synthesis and Biological Evaluation of 1,3-Dideazapurine-Like 7-Amino-5-Hydroxymethyl-Benzimidazole Ribonucleoside Analogues as Aminoacyl-tRNA Synthetase Inhibitors.

Authors:  Baole Zhang; Luping Pang; Manesh Nautiyal; Steff De Graef; Bharat Gadakh; Eveline Lescrinier; Jef Rozenski; Sergei V Strelkov; Stephen D Weeks; Arthur Van Aerschot
Journal:  Molecules       Date:  2020-10-16       Impact factor: 4.411

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.